Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes.
AIMS/HYPOTHESIS: There are strong associations between measures of inflammation and type 2 diabetes, but the causal directions of these associations are not known. We tested the hypothesis that common gene variants known to alter circulating levels of inflammatory proteins, or known to alter autoim...
| Váldodahkkit: | , , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Journal article |
| Giella: | English |
| Almmustuhtton: |
2008
|
| _version_ | 1826259398598590464 |
|---|---|
| author | Rafiq, S Melzer, D Weedon, M Lango, H Saxena, R Scott, L Palmer, C Morris, A McCarthy, M Ferrucci, L Hattersley, A Zeggini, E Frayling, T |
| author_facet | Rafiq, S Melzer, D Weedon, M Lango, H Saxena, R Scott, L Palmer, C Morris, A McCarthy, M Ferrucci, L Hattersley, A Zeggini, E Frayling, T |
| author_sort | Rafiq, S |
| collection | OXFORD |
| description | AIMS/HYPOTHESIS: There are strong associations between measures of inflammation and type 2 diabetes, but the causal directions of these associations are not known. We tested the hypothesis that common gene variants known to alter circulating levels of inflammatory proteins, or known to alter autoimmune-related disease risk, influence type 2 diabetes risk. METHODS: We selected 46 variants: (1) eight variants known to alter circulating levels of inflammatory proteins, including those in the IL18, IL1RN, IL6R, MIF, PAI1 (also known as SERPINE1) and CRP genes; and (2) 38 variants known to predispose to autoimmune diseases, including type 1 diabetes. We tested the associations of these variants with type 2 diabetes using a meta-analysis of 4,107 cases and 5,187 controls from the Wellcome Trust Case Control Consortium, the Diabetes Genetics Initiative, and the Finland-United States Investigation of NIDDM studies. We followed up associated variants (p < 0.01) in a further set of 3,125 cases and 3,596 controls from the UK. RESULTS: We found no evidence that inflammatory or autoimmune disease variants are associated with type 2 diabetes (at p |
| first_indexed | 2024-03-06T18:49:14Z |
| format | Journal article |
| id | oxford-uuid:0f9d1f95-34be-47c3-9ecd-d6d517bf0770 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T18:49:14Z |
| publishDate | 2008 |
| record_format | dspace |
| spelling | oxford-uuid:0f9d1f95-34be-47c3-9ecd-d6d517bf07702022-03-26T09:52:15ZGene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0f9d1f95-34be-47c3-9ecd-d6d517bf0770EnglishSymplectic Elements at Oxford2008Rafiq, SMelzer, DWeedon, MLango, HSaxena, RScott, LPalmer, CMorris, AMcCarthy, MFerrucci, LHattersley, AZeggini, EFrayling, T AIMS/HYPOTHESIS: There are strong associations between measures of inflammation and type 2 diabetes, but the causal directions of these associations are not known. We tested the hypothesis that common gene variants known to alter circulating levels of inflammatory proteins, or known to alter autoimmune-related disease risk, influence type 2 diabetes risk. METHODS: We selected 46 variants: (1) eight variants known to alter circulating levels of inflammatory proteins, including those in the IL18, IL1RN, IL6R, MIF, PAI1 (also known as SERPINE1) and CRP genes; and (2) 38 variants known to predispose to autoimmune diseases, including type 1 diabetes. We tested the associations of these variants with type 2 diabetes using a meta-analysis of 4,107 cases and 5,187 controls from the Wellcome Trust Case Control Consortium, the Diabetes Genetics Initiative, and the Finland-United States Investigation of NIDDM studies. We followed up associated variants (p < 0.01) in a further set of 3,125 cases and 3,596 controls from the UK. RESULTS: We found no evidence that inflammatory or autoimmune disease variants are associated with type 2 diabetes (at p |
| spellingShingle | Rafiq, S Melzer, D Weedon, M Lango, H Saxena, R Scott, L Palmer, C Morris, A McCarthy, M Ferrucci, L Hattersley, A Zeggini, E Frayling, T Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes. |
| title | Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes. |
| title_full | Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes. |
| title_fullStr | Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes. |
| title_full_unstemmed | Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes. |
| title_short | Gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes. |
| title_sort | gene variants influencing measures of inflammation or predisposing to autoimmune and inflammatory diseases are not associated with the risk of type 2 diabetes |
| work_keys_str_mv | AT rafiqs genevariantsinfluencingmeasuresofinflammationorpredisposingtoautoimmuneandinflammatorydiseasesarenotassociatedwiththeriskoftype2diabetes AT melzerd genevariantsinfluencingmeasuresofinflammationorpredisposingtoautoimmuneandinflammatorydiseasesarenotassociatedwiththeriskoftype2diabetes AT weedonm genevariantsinfluencingmeasuresofinflammationorpredisposingtoautoimmuneandinflammatorydiseasesarenotassociatedwiththeriskoftype2diabetes AT langoh genevariantsinfluencingmeasuresofinflammationorpredisposingtoautoimmuneandinflammatorydiseasesarenotassociatedwiththeriskoftype2diabetes AT saxenar genevariantsinfluencingmeasuresofinflammationorpredisposingtoautoimmuneandinflammatorydiseasesarenotassociatedwiththeriskoftype2diabetes AT scottl genevariantsinfluencingmeasuresofinflammationorpredisposingtoautoimmuneandinflammatorydiseasesarenotassociatedwiththeriskoftype2diabetes AT palmerc genevariantsinfluencingmeasuresofinflammationorpredisposingtoautoimmuneandinflammatorydiseasesarenotassociatedwiththeriskoftype2diabetes AT morrisa genevariantsinfluencingmeasuresofinflammationorpredisposingtoautoimmuneandinflammatorydiseasesarenotassociatedwiththeriskoftype2diabetes AT mccarthym genevariantsinfluencingmeasuresofinflammationorpredisposingtoautoimmuneandinflammatorydiseasesarenotassociatedwiththeriskoftype2diabetes AT ferruccil genevariantsinfluencingmeasuresofinflammationorpredisposingtoautoimmuneandinflammatorydiseasesarenotassociatedwiththeriskoftype2diabetes AT hattersleya genevariantsinfluencingmeasuresofinflammationorpredisposingtoautoimmuneandinflammatorydiseasesarenotassociatedwiththeriskoftype2diabetes AT zegginie genevariantsinfluencingmeasuresofinflammationorpredisposingtoautoimmuneandinflammatorydiseasesarenotassociatedwiththeriskoftype2diabetes AT fraylingt genevariantsinfluencingmeasuresofinflammationorpredisposingtoautoimmuneandinflammatorydiseasesarenotassociatedwiththeriskoftype2diabetes |